Manufacturer Oxford hid from volunteers a major error in testing for the corona virus vaccine. In this case a mistake is made in the quantitative aspect of the dose. But the volunteers are kept in the dark about that. Oxford / AstraZeneca tested the wrong dose on about 1,500 volunteers. But even after being caught in this horrible mistake, they suppressed the matter. News agency Reuters has received the relevant documents. They gave this news based on him. In a letter dated June 6, researchers at the University of Oxford were told that vaccine participants were confused about the dose of vaccine.
Researchers are told how different doses work. The letter was signed by Andrew J. Oxford, the chief investigator of the test. Pollard. On December 24, Reuters reported that Oxford researchers had mistakenly administered a half-dose vaccine to test participants. However, Pollard's letter did not acknowledge any wrongdoing. The letter did not even mention that the researchers had reported the matter to British medical regulators. Regulators then told Oxford to add another test group to the test to take the full dose. However, it was not known whether there was any risk to the health of the participants.
Note that the demand for this vaccine invented by Oxford in Britain is quite high. The vaccine has spread throughout Britain. It is seen as the least expensive vaccine in the fight against the corona epidemic. But there is a lack of information on the effectiveness of this vaccine in older people due to dosage errors in Oxford tests. For this reason, the surveillance towards this ticker has increased. Reuters received the letter requesting freedom of information. It has since been shared with at least three different medical experts. They all said there were indications that the researchers did not appear to have maintained transparency with test participants during their experiments.
There is a rule to inform the volunteers of all the information in case of any change in the clinical examination. Oxford spokesman Steve Pritchard said there were no plans to administer the half-dose vaccine to volunteers. However, we do know that there was some discrepancy in the dose measurement and we have discussed this with the regulators. "We are not saying that there was anything wrong with the dosage," he said.
What the spokesperson said is that there was no mistake in this case. However, his statement contradicted the documents provided last year by Oxford and its partner in the field of vaccines, AstraZeneca. Last December, Reuters reported that on November 18, Reuters published a report on the Oxford / Estrogen Gene's 'Global Statistical Analysis Plan'. The report was later published in The Lancet, a British science journal. It mentions that inequality in dosage application is a big mistake. A spokesman for AstraZeneca declined to comment.
